Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M691Revenue (TTM) $M37.0Net Margin (%)-387.1Altman Z-Score-8.3
Enterprise Value $M726EPS (TTM) $-1.3Operating Margin %-331.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score-6.5Pre-tax Margin (%)-386.9Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsY
Price/Sales18.35-y EBITDA Growth Rate %29.3Current Ratio5.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-81.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-712.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M108ROIC % (ttm)-358.9Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

KERX is held by these investors:



KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Madison GregPresident and CEO 2017-05-01Sell4,122$5.976.03view
Neylan John F.Chief Medical Officer 2017-05-01Sell1,441$5.976.03view
Holmes Scott ACFO 2017-05-01Sell1,441$5.976.03view
Adams BrianGeneral Counsel and Secretary 2017-05-01Sell1,441$5.976.03view
Holmes Scott ACFO 2017-04-28Sell1,219$5.897.47view
Neylan John F.Chief Medical Officer 2017-04-24Sell1,209$5.7310.47view
Adams BrianGeneral Counsel and Secretary 2017-04-17Sell1,090$5.7510.09view
Madison GregPresident and CEO 2017-04-05Sell911$5.89.14view
Adams BrianGeneral Counsel and Secretary 2017-04-05Sell642$5.89.14view
Madison GregPresident and CEO 2017-02-09Sell1,611$5.4715.72view

Press Releases about KERX :

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results May 04 2017 
Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D P May 01 2017 
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on Thursday Apr 18 2017 
Keryx Announces the Largest Medicare Part D Plan Sponsor Added Auryxia® to its Medicare Part D Pl Mar 20 2017 
Keryx Biopharmaceuticals Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application f Mar 08 2017 
Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 

More From Other Websites
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : May 22, 2017 May 22 2017
Top 4 Pharmaceutical Stocks for 2017 May 19 2017
Edited Transcript of KERX earnings conference call or presentation 4-May-17 12:00pm GMT May 10 2017
Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 May 09 2017
Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat May 05 2017
Today's Research Reports on Biotech Stocks to Watch: BioCryst Pharmaceuticals and Keryx... May 05 2017
Keryx Biopharma reports 1Q loss May 04 2017
Keryx (KERX) Posts Wider-than-Expected Q1 Loss, Sales Beat May 04 2017
Investor Network: Keryx Biopharmaceuticals, Inc. to Host Earnings Call May 04 2017
Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results May 04 2017
Keryx Announces that Auryxia® (Ferric Citrate) is Now on Formulary at All Major Medicare Part D... May 01 2017
What to Expect from Keryx (KERX) Stock This Earnings Season? Apr 28 2017
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2017 Financial Results on... Apr 18 2017
Lawsuit for Investors in NASDAQ: KERX Shares Against Keryx Biopharmaceuticals Announced by... Apr 10 2017
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : April 7, 2017 Apr 07 2017
Here's Why Keryx Biopharmaceuticals Jumped 27.3% in March Apr 07 2017
Why Is Keryx (KERX) Up 27.4% Since the Last Earnings Report? Apr 04 2017
Keryx's Auryxia Added to Largest Medicare Part D Plan Mar 22 2017
Omeros and Keryx are Potential Beneficiaries of New Administration Deregulation Mar 21 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat